Although further investigation is needed to better understand these mechanisms, our studies show that EDNRA expression and the proportion of EDNRA+ cells in the interstitial myelomatous BM can serve as biomarkers of disease progression in MM. Here, EDNRA is linked to Miyoshi myopathy.